Abstract
Fourteen years after transplantation into the striatum of an individual with Parkinson's disease, grafted nigral neurons were found to have Lewy body–like inclusions that stained positively for α-synuclein and ubiquitin and to have reduced immunostaining for dopamine transporter. These pathological changes suggest that Parkinson's disease is an ongoing process that can affect grafted cells in the striatum in a manner similar to host dopamine neurons in the substantia nigra. These findings have implications for cell-based therapies and for understanding the cause of Parkinson's disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Olanow, C.W. et al. Ann. Neurol. 54, 403–414 (2003).
Freed, C.R. et al. N. Engl. J. Med. 344, 710–719 (2001).
Sawle, G.V. et al. Ann. Neurol. 31, 166–173 (1992).
Piccini, P. et al. Nat. Neurosci. 2, 1137–1140 (1999).
Kordower, J.H. et al. N. Engl. J. Med. 332, 1118–1124 (1995).
Kordower, J.H. et al. J. Comp. Neurol. 370, 203–230 (1996).
Kordower, J.H. et al. Cell Transplant. 6, 213–219 (1997).
Mendez, I. et al. Brain 128, 1498–1510 (2005).
Braak, H. et al. Neurobiol. Aging 24, 197–211 (2003).
Chu, Y. & Kordower, J.H. Neurobiol. Dis. 25, 134–149 (2007).
Olanow, C.W. et al. Lancet Neurol. 3, 496–503 (2004).
Acknowledgements
We would like to thank G. Folino for histological assistance.
Author information
Authors and Affiliations
Contributions
J.H.K. and Y.C. performed the histological analysis. R.A.H. performed the clinical assessments. T.B.F. did brain ascertainment. J.H.K., R.A.H., T.B.F. and C.W.O. wrote the manuscript. C.W.O., T.B.F. and J.H.K. designed the original open label transplant trial. T.B.F. and C.W.O. implemented the original clinical transplant trial.
Corresponding author
Ethics declarations
Competing interests
J.H.K. is a consultant for Ceregene, Inc., Brainstorm, Inc. and Nupathe, Inc. C.W.O. is a consultant for Ceregene, Inc. These companies could benefit from the results of this study.
Supplementary information
Supplementary Text and Figures
Supplementary Figs. 1 and 2 (PDF 2618 kb)
Rights and permissions
About this article
Cite this article
Kordower, J., Chu, Y., Hauser, R. et al. Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14, 504–506 (2008). https://doi.org/10.1038/nm1747
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1747
This article is cited by
-
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19
Acta Neuropathologica Communications (2024)
-
Cell-therapy for Parkinson’s disease: a systematic review and meta-analysis
Journal of Translational Medicine (2023)
-
Challenges in the clinical advancement of cell therapies for Parkinson’s disease
Nature Biomedical Engineering (2023)
-
AAV-mediated expression of a new conformational anti-aggregated α-synuclein antibody prolongs survival in a genetic model of α-synucleinopathies
npj Parkinson's Disease (2023)
-
Tunnelling nanotubes between neuronal and microglial cells allow bi-directional transfer of α-Synuclein and mitochondria
Cell Death & Disease (2023)